145 related articles for article (PubMed ID: 17566476)
1. Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?
McGuire BB; O'Brien MF; McLoughlin S; O'Malley KJ; Fitzpatrick JM
Ir Med J; 2007 Apr; 100(4):428-9. PubMed ID: 17566476
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)].
Horchani A; Binous MY; Ben Hamida A; Sallami S; El Adbi H; Naji A
Tunis Med; 2007 Aug; 85(8):619-24. PubMed ID: 18254279
[TBL] [Abstract][Full Text] [Related]
3. Effects of a shared protocol between urologists and general practitioners on referral patterns and initial diagnostic management of men with lower urinary tract symptoms in Italy: the Prostate Destination study.
Spatafora S; Canepa G; Migliari R; Rotondo S; Mandressi A; Puppo P;
BJU Int; 2005 Mar; 95(4):563-70. PubMed ID: 15705081
[TBL] [Abstract][Full Text] [Related]
4. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial.
Carballido J; Fourcade R; Pagliarulo A; Cricelli C; Brenes F; Pedromingo-Marino A; Castro R
Int J Clin Pract; 2009 Aug; 63(8):1192-7. PubMed ID: 19558487
[TBL] [Abstract][Full Text] [Related]
5. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
6. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
Roehrborn CG
BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
[TBL] [Abstract][Full Text] [Related]
7. A decision aid for GPs for the treatment of elderly male patients with lower urinary tract symptoms (LUTS).
Norg RJ; Portegijs PJ; van de Beek K; van Schayck O; Knottnerus JA
Fam Pract; 2006 Dec; 23(6):666-73. PubMed ID: 16971394
[TBL] [Abstract][Full Text] [Related]
8. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic procedures by Italian general practitioners in response to lower urinary tract symptoms in male patients: a prospective study.
Spatafora S; Canepa G; Migliari R; Rotondo S; Mandressi A; Puppo P
Curr Med Res Opin; 2004 May; 20(5):713-21. PubMed ID: 15140338
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of lower urinary tract symptoms among men in general practice and in hospitals].
Nørby B; Dørflinger T
Ugeskr Laeger; 2007 May; 169(20):1923-5. PubMed ID: 17553374
[TBL] [Abstract][Full Text] [Related]
11. Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.
Rosen RC; Wei JT; Althof SE; Seftel AD; Miner M; Perelman MA;
Urology; 2009 Mar; 73(3):562-6. PubMed ID: 19167031
[TBL] [Abstract][Full Text] [Related]
12. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
Fourcade RO; Théret N; Taïeb C;
BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
[TBL] [Abstract][Full Text] [Related]
13. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
14. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
[TBL] [Abstract][Full Text] [Related]
15. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.
Barqawi AB; Myers JB; O'Donnell C; Crawford ED
BJU Int; 2007 Oct; 100(4):853-7. PubMed ID: 17662074
[TBL] [Abstract][Full Text] [Related]
16. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
18. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life assessment of the male with benign prostate hypertrophy].
Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
[TBL] [Abstract][Full Text] [Related]
20. [Uneven quality of referrals for lower urinary tract symptoms in men].
Hedelin H; Johansson N; Ströberg P
Lakartidningen; 2003 Apr; 100(16):1435-7. PubMed ID: 12756711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
